Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Shares of Novo Nordisk (NYSE:NVO) fell 2% following the announcement of results from its STEP UP obesity trial, which showed ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

Also in today’s edition: ‘no-show’ international student data and significant progress in Israel-Hamas ceasefire talks ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

CMS is expected to publish up to 15 drugs for the second cycle of the program by Feb. 1, and these are some of the drugs most ...